Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04503577

Prospective Bladder Cancer Infrastructure (ProBCI)

Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bladder Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Site Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Bladder cancer
  • Any stage except Ta
  • 18 years or older
  • Written informed consent

Exclusion criteria

  • No exclusion criteria

Note: participation in ProBCI does not exclude the patient from participation in other studies.

Treatment and study plan

Primary outcomes

  1. Overall survival

    Time frame: 10 years

    Alive/death/emigrated

Secondary outcomes

  1. Progression-free survival

    Time frame: 10 yeas

    Progression/no progression

  2. Recurrence-free survival

    Time frame: 10 yeas

    Recurrence/no recurrence

  3. Health-related quality of life

    Time frame: 2 years

    EQ-5D (EuroQol-Five Dimensions)

  4. Cancer-specific health-related quality of life

    Time frame: 2 years

    QLQ-C30 (Quality of Life Questionnaire-Cancer)

Study contacts

Contact information is provided by the study sponsor or research team.

A. Richters, PhD

CONTACT

[email protected]

0031623237842

Sponsors and collaborators

Lead sponsor

Prospective Bladder Cancer Infrastructure Foundation

Other

Registry information

Official study title

Prospective Bladder Cancer Infrastructure: an Infrastructure for Observational and Interventional Bladder Cancer Research (ProBCI)

Acronym: ProBCI

Important dates

Study start
2020
Primary completion
2040
Study completion
2041
First posted
Aug 7, 2020
Registry last updated
Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.